Cantor Fitzgerald Maintains Overweight on Eli Lilly, Raises Price Target to $1230

Cantor Fitzgerald analyst Carter Gould maintains Eli Lilly (NYSE:LLY) with a Overweight and raises the price target from $1205 to $1230.